Moderna, Inc. (NASDAQ:MRNA) | Finanzwire

Basculer en Français

10591	Companies
224588	Keywords
153314	Articles
118796	Press releases

Home
Companies
Moderna, Inc.

PRESS RELEASE

published on 02/14/2025 at 12:28, 1 year 4 months ago

Moderna Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Updates
Moderna, Inc. reports Q4 revenues of $1.0B with a net loss of $(1.1)B. Forecasts 2025 revenue of $1.5-2.5B. Submitted 3 mRNA products for regulatory approval. Financial details and pipeline updates disclosed

Revenues Net Loss Moderna MRNA Products 2025 Revenue
BRIEF

published on 01/29/2025 at 13:05, 1 year 4 months ago

Moderna to Announce Financial Results for Q4 and 2024

Financial Results Webcast Corporate Update MRNA Technology Moderna
PRESS RELEASE

published on 01/29/2025 at 13:00, 1 year 4 months ago

Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
Moderna, Inc. to host conference call on February 14, 2025 to report Q4 and full year 2024 financial results, and provide a corporate update. Details on webcast available on Moderna website

Financial Results Conference Call Webcast Moderna Inc. MRNA Medicine
BRIEF

published on 01/24/2025 at 12:35, 1 year 4 months ago

Moderna Secures EU Tender for mRNA COVID-19 Vaccine Supply

COVID-19 Moderna MRNA Vaccine Spikevax EU Tender
PRESS RELEASE

published on 01/24/2025 at 12:30, 1 year 4 months ago

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union
Moderna awarded tender to supply mRNA COVID-19 vaccine in EU, Norway, and North Macedonia, offering diverse formats like prefilled syringes. Enhancing vaccination campaigns with efficient options

COVID-19 Moderna MRNA Vaccine Vaccination Campaigns Prefilled Syringes
BRIEF

published on 01/17/2025 at 22:33, 1 year 5 months ago

Moderna Advances mRNA-Based Influenza Vaccine Development

Clinical Trials Moderna MRNA Vaccines BARDA Funding Influenza
PRESS RELEASE

published on 01/17/2025 at 22:28, 1 year 5 months ago

Moderna Announces Updates on Pandemic Influenza Program
Moderna announces ongoing support from HHS to accelerate mRNA-based pandemic influenza vaccines development. Award received through BARDA-funded RRPV Consortium

Moderna MRNA BARDA HHS Pandemic Influenza Vaccines
BRIEF

published on 01/13/2025 at 13:05, 1 year 5 months ago

Moderna Outlines Strategic Moves at J.P. Morgan Healthcare Conference

Cost Reduction Plan Vaccine Approvals Moderna Financials 2025 Revenue Forecast Pipeline Milestones
PRESS RELEASE

published on 01/13/2025 at 13:00, 1 year 5 months ago

Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Moderna, Inc. announces 2024 financial achievements and 2025 projections with emphasis on revenue growth, cost reductions, and pipeline milestones including COVID-19 and flu vaccines

Revenue Growth Financial Updates Moderna Cost Reductions Pipeline Milestones
BRIEF

published on 11/25/2024 at 13:05, 1 year 6 months ago

Moderna to Present at December 2024 Investor Conferences

Investor Conferences Healthcare Webcast MRNA Technology Moderna

Accesswire

Published on 06/18/2026 at 00:00, 6 hours 48 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 7 hours 18 minutes ago

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 7 hours 58 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 8 hours 18 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 13 hours 53 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 06:30, 17 minutes ago

Schindler Holding Ltd. increases ongoing share buyback program to up to CHF 700 million
Published on 06/18/2026 at 04:05, 2 hours 42 minutes ago

Hisense Brings Smarter Home Experiences to Families During the FIFA World Cup 2026™
Published on 06/18/2026 at 02:45, 4 hours 3 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter
Published on 06/17/2026 at 21:40, 9 hours 7 minutes ago

Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 11 hours 38 minutes ago

Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa

Les Echos

Published on 06/17/2026 at 17:40, 13 hours 8 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 22 hours 3 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 19 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 7 hours ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 11 hours ago

Reporting on share buyback transactions carried out between June 8 and June 11, 2026

View all LES ECHOS COMFI WIRE